Skip to main content

Veterinary Reference Laboratory Market Global Forecasts to 2021

The report Veterinary Reference Laboratory Market by Technology (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics) Application (Pathology, Bacteriology, Virology, Parasitology) Animal (Dog, Cat, Cattle, Pig) – Global Forecast to 2021″ , analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

The veterinary reference laboratories market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 9.8% between 2016 and 2021 to reach 2.76 Billion by 2021.
Browse 202 market data tables with 36 figures spread through 217 pages and in-depth TOC on “Veterinary Reference Laboratory Market”  

http://www.marketsandmarkets.com/Market-Reports/veterinary-reference-laboratory-market-256972714.html

Industry Insights:

The growth in this market is majorly attributed to factors such as rising animal healthcare expenditure, rising pet adoption, increasing demand for pet insurance, growing demand for animal-derived food products, increasing number of veterinary practitioners and their growing income levels in developed regions, and rising awareness about zoonotic diseases.

In this report, the veterinary reference laboratory market is segmented on the basis of technology, application, animal type, and region. On the basis of technology, the market is segmented into clinical chemistry, hematology, immunodiagnostics, and molecular diagnostics. The clinical chemistry accounted for the largest share of the global veterinary reference laboratory market in 2015 owing to its wide utilization by the reference laboratories for the diagnosis and monitoring of disease conditions in animals.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=256972714

 Geographical Scenario: 
Geographically, the global veterinary reference laboratory market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to rising companion animal population, increase in the demand for animal-derived food products and increasing adoption of diagnostic products and services for diagnosis and treatment of animals.

Scope of the Report:
This report categorizes the veterinary reference laboratory market market into the following segments:
  • Global Veterinary Reference Laboratory Market, by Technology
  • Global Veterinary Reference Laboratory Market, by Application
  • Global Veterinary Reference Laboratory Market, by type of Animal
  • Global Veterinary Reference Laboratory Market, by Region
Request a sample of the report:
http://www.marketsandmarkets.com/requestsample.asp?id=256972714

Target Audience:
  • Veterinary Reference Laboratory
  • Veterinary hospitals and clinics
  • Animal Health Research and Development (R&D) Companies
  • Government Associations
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors
Industry Leaders:
The market players, namely, IDEXX Laboratories, (U.S.), VCA, Inc. (U.S.), and GD Animal Health (Netherlands) held the major share of the veterinary reference laboratories market and will continue to dominate the market between 2016 and 2021.

Some of the other players operating in this market are National Veterinary Services Laboratory (U.S.), Animal and Plant Health Agency (DEFRA APHA Scientific) (U.K.), Animal Health Diagnostic Center (Cornell University) (U.S.), Greencross Limited (Australia), Gribbles Veterinary Pathology (Australia), Phoenix Central Laboratory for Veterinarians, Inc. (U.S.), Zoetis, Inc. (U.S.), Neogen Corporation (U.S.), ProtaTek Internationals Inc. (U.S.), Wisconsin Veterinary Diagnostic Laboratory (U.S.), and Washington State University Veterinary Clinical Pathology Laboratory (U.S.).

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
E-mail: sales@marketsandmarkets.com
Tel: 1-888-600-6441

Article Credit:  https://healthcaredc.wordpress.com/2017/10/03/veterinary-reference-laboratory-market-global-forecasts-to-2021/

Comments

Popular posts from this blog

NGS-Based RNA-Sequencing Industry is Growing at a CAGR of 20%

NGS-based RNA-sequencing Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market. NGS-based RNA-sequencing Market: Impact Analysis 1. NGS-Based RNA-Sequencing: Market Overview 2. Geographical Snapshot of the NGS-Based RNA-Sequencing Market 3. Rapid Growth in Precision Medicine 4. Growing Number of Research Activities Involving RNA-Seq 5. Increasing Applications of RNA-Seq in Research ( Cancer and Agricultural) The NGS-based RNA-sequencing market size is estimated to grow from USD 1.7 billion in 2019 to USD 4.2 billion by 2024, at a CAGR of 20.0%. Key Questions Addressed in The Report: 1. Who are the top 10 players operating in the global NGS-based RNA-sequencing market? 2. What are the drivers, restraints, opportunities, and challenges in the NGS-based RNA-sequencing Industry? 3. What are th...

Digital Diabetes Management Market to Reach $19.98 billion by 2024 | Market and Regional Growth Analysis

  Digital diabetes management solutions are smartphone-connected diabetes management devices and software platforms used by patients suffering from Type 1, Type 2, and gestational diabetes. Medical professionals also use these solutions to manage diabetes. Various digital diabetes management devices such as smart glucose meters, continuous glucose monitoring systems, smart insulin pens, and smart insulin pumps/closed-loop systems and smart insulin patches are used for glucose monitoring and insulin delivery. Diabetes management applications, data management software & platforms, and services are used by patients and healthcare providers for remote monitoring, data analysis, and disease management. The Digital Diabetes Management Market is experiencing significant growth due to rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly...

Epigenetics Market | Major Market Dynamics Impacting The Global Industry

Epigenetics refers to the covalent modification of DNA, RNA, or protein that results in changes to the function and/or regulation of these molecules, without altering their primary sequences. These modifications can occur naturally, or can be influenced, by several factors including age, environment, disease state, and changes in lifestyle. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years. The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strateg...